[1] E1-Youssef M,Mu Y,Huang L,et a1. Increased expression of transforming growth factor:beta1 and thrombospondin-1 in congenital hepatic fibrosis:possible role of the hepatic stellate cell. J Pediatr Gastroenterol Nutr,1999,28（4）:386-392.
[2] 赵新颜,王宝恩,贾继东. 36例先天性肝纤维化的临床病理特点. 中华消化杂志,2005,25（12）:748-749.
[3] 张云霞,闫涛,汤汝佳,等.17例先天性肝纤维化临床和病理分析.实用肝脏病杂志,2010,13（6）:446-448.
[4] Hsu CM,Chiu CT,Lien JM,et al. Severe portopulmonary hypertension in congenital hepatic fibrosis. Chang Gung Med,2003,26（3）:193-198.
[5] Mindikoglu AL,Regev A,O'Sullivan MJ,et al. Multiple normal deliveries in a woman with severe portal hypertension due to congenital hepatic fibrosis:the importance of preserved hepatocellular function. Am J Gastroenterol,2005,100（10）:2359-2361.
[6] 汤汝佳,刘振文,苏海滨,等.先天性肝纤维化48例临床特点分析.肝脏,2013,18（2）:75-76.
[7] Yonem O,Ozkayar N,Balkanci F,et a1. Is congenital hepatic fibrosis a pure liver disease. Am J Gastroenterol,2006,101（6）:253-1259.
[8] Mohammad RG,Mohammad B,Amir HG. Congenital hepatic fibrosis leading to cirrhosis and hepatocellular carcinoma:a case report. J Med Case Rep,2011,5:160.
[9] Eugene RS,Willis CM,Michaele ES,et al. Schiff , s diseases of the liver. 10th ed. New Jersey,A John Wiley & Sons,Ltd, Publication. 2005,211-216.
[10] Rossi S,Assis DN,Awsare M,et al. Use of over the-counter analgesics in patients with chronic liver disease:physicians' recommendations. Drug Saf,2008,31:261-270.
[11] 姚东升,刘平,胡义扬,等. 中医药治疗代谢综合征研究进展.中华中医院学刊,2013,31（5）:1113-1115.
[12] 王晓峰,王立峰. 非酒精性脂肪性肝炎的病理学诊断.实用肝脏病杂志,2013,16（6）:486-489.
[13] 赵彩彦,曹伟.非酒精脂肪性肝炎的诊断. 实用肝脏病杂志,2013,16（6）:490-492.
[14] 施军平,荀运浩. 非酒精性脂肪性肝病治疗进展.实用肝脏病杂志,2013,16（6）:493-495.
[15] Chalasani N,Younossi Z,Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Association for the Study of Liver Diseases,American College of Gastroenterology and the American Gastroenterological Association. Hepatology,2012,55:2005-2023.
[16] 胡义扬. 加强中医药治疗脂肪性肝病的深入研究. 中国中西医结合杂志,2004,24（1）：12.
[17] 刘平. 重视肝纤维化的病理生理机制与治疗学研究.中华肝脏病杂志,2010,18（8）：561-562. |
